ODDB.org: Open Drug Database

Swissmedic Registration	67280	Date of registration	05.11.2020
Company name	Roche Pharma (Schweiz) AG	Revision date
		Valid until	20.07.2028
Indication		Date of market entry
Index Therapeuticus (BSV)	07.16.10.	Revocation Date
Index Therapeuticus (Swissmedic)	07.16.10.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Rozlytrek 100 mg	Hartkapseln	Capsules (Entrectinibum 100 mg)	L01EX14	CI
02	Rozlytrek 200 mg	Hartkapseln	Capsules (Entrectinibum 200 mg)	L01EX14

2025	©ywesee GmbH